skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: New myocardial imaging agents: stabilization of radioiodine as a terminal vinyl iodide moiety on tellurium fatty acids

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00363a014· OSTI ID:5656158

To determine the myocardial uptake and retention properties of radioiodinated tellurium fatty acids, we prepared two new tellurium fatty acids in which iodine-/sup 125/ has been chemically stabilized by attachment as a trans-vinyl iodide (I-CH . CH-R-Te-R'-COOH) and evaluated them in rats. Fabrication of 18-iodo-13-tellura-17-octadecenoic acid was accomplished by coupling 1,5-diiodo-1-pentene with sodium 12-(methoxycarbonyl)-n-dodecan-1-yl telluride. The (5-/sup 125/I)-1,5-diiodo-1-pentene was prepared by an organoborane technique involving /sup 125/I+ treatment of 5-iodo-1-penten-1-ylboronic acid (I(CH/sub 2/)/sub 3/CH . CHB(OH)/sub 2/). The absolute heart uptake of this agent was moderate (1.47-2.52% dose/g after 60 min), but the heart/blood ratios were low (approximately 2.6:1). Only marginal in vivo deiodination occurred, since the thyroid uptake was low (15-18% dose/g after 60 min). The effect of tellurium in position 13 was unexpected. To determine if the low heart specificity and low heart/blood ratios were dependent upon the position of the tellurium, we prepared an analogue with the same chain length, 18-(/sup 125/I)iodo-7-tellura-17-octadecenoic acid, in the same manner by reaction of (11-/sup 125/I)-1,11-diiodo-1-undecene with sodium 6-(methoxycarbonyl)-n-hexan-1-yl telluride. This agent showed pronounced heart uptake (2.47-3.94% dose/g after 60 min) and prolonged retention (1.76-3.14% dose/g after 4 h) in rats. Furthermore, the heart/blood ratios remained high for several hours (13:1 after 60 min; 9:1 after 4 h). Iodine-123 labeled 18-iodo-7-tellura-17-octadecenoic acid is an attractive new compound for evaluation as a myocardial imaging agent.

Research Organization:
Nuclear Medicine Group, Health and Safety Research Division, Oak Ridge National Laboratory, Tennessee
OSTI ID:
5656158
Journal Information:
J. Med. Chem.; (United States), Vol. 26:9
Country of Publication:
United States
Language:
English

Similar Records